| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 31,028 shares worth roughly $11.3M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
ONC sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 397.9K | - | - | |
| Dir | 161.6K | - | - | |
| Other | 99.6K | $25.66M | - | |
| Dir | 83.7K | - | - | |
| Dir | 73.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Wang Lai50 | President, Global Head of R&D | Sell | 756 | $261.00 | $197,317.59 | -100% | +34.9% | - | |
| Jun 11, 2026 | Lee Chan Henry49 | SVP, General Counsel | Sell | 428 | $257.64 | $110,267.78 | -100% | +34.9% | - | |
| Jun 11, 2026 | Rosenberg Aaron | Chief Financial Officer | Sell | 631 | $257.74 | $162,636.53 | -100% | +34.9% | - | |
| Jun 11, 2026 | Wu Xiaobin52 | President and COO | Sell | 626 | $261.20 | $163,512.26 | -100% | +34.9% | - | |
| Jun 8, 2026 | Ball Titus B. | Principal Accounting Officer | Sell | 136 | $271.33 | $36,900.64 | -100% | +29.8% | - | |
| Jun 8, 2026 | Oyler John58 | Chief Executive Officer | Sell | 4,940 | $270.56 | $1,336,547.59 | -100% | +29.8% | - | |
| Jun 8, 2026 | Lee Chan Henry49 | SVP, General Counsel | Sell | 871 | $270.42 | $235,539.14 | -100% | +29.8% | - | |
| Jun 8, 2026 | Wang Lai50 | President, Global Head of R&D | Sell | 1,367 | $269.38 | $368,246.83 | -100% | +29.8% | - | |
| Jun 8, 2026 | Wu Xiaobin52 | President and COO | Sell | 1,484 | $269.37 | $399,738.13 | -100% | +29.8% | - | |
| Jun 1, 2026 | Yi Qingqing | Director | Sell | 235 | $279.13 | $65,595.55 | -100% | +28.6% | - |